InnoCare Pharma (INCPF) Stock Price, News & Analysis

Company Overview

InnoCare Pharma (OTCMKTS: INCPF) is a China-based integrated biopharmaceutical company focused on the research, development and commercialization of innovative therapies in the fields of immunology and oncology. The company’s R&D platform encompasses both small-molecule drugs and biologics, with particular emphasis on monoclonal antibodies that target pro-inflammatory cytokines and immune checkpoints.

InnoCare Pharma’s pipeline includes multiple clinical and preclinical candidates aimed at addressing chronic inflammatory diseases and various cancer indications. The company has invested in state-of-the-art research facilities and manufacturing capabilities to support process development, scale-up and quality control. Strategic collaborations with academic institutions and contract research organizations help accelerate compound discovery and clinical translation.

Serving primarily the Greater China region, InnoCare Pharma is pursuing partnerships and licensing agreements to expand its geographic reach and bring its therapies to broader patient populations. The company’s management team combines seasoned biopharmaceutical executives and scientific leaders with extensive experience in drug development and commercialization, positioning InnoCare Pharma to advance its pipeline toward late-stage clinical trials and global regulatory approvals.

Key Stats

• Today's Range: $3.26 to $3.26
• 50-Day Range: $3.26 to $3.26
• 52-Week Range: $3.26 to $3.72
• Volume: N/A
• Average Volume: 3,450 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

INCPF Stock Analysis - Frequently Asked Questions

How have INCPF shares performed this year?

InnoCare Pharma's stock was trading at $3.26 at the beginning of the year. Since then, INCPF shares have increased by 0.0% and is now trading at $3.26.

How do I buy shares of InnoCare Pharma?

Shares of INCPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 8/06/2025
• Next Earnings (Estimated): 8/18/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:INCPF
• CIK: N/A
• Web: www.innocarepharma.com
• Phone: 861066609999
• Fax: N/A
• Employees: 1,089
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A